References
- Sperelakis N. Regulation of calcium slow channels in myocardial cells by cyclic nucleotides and phosphorylation. Protein Phosphorylation in Heart Muscle, R. J. Solaro. CRC Press, Boca Raton, FL 1986; 55–83
- Kohlhardt M, Haap K. 8-Bromo-guanosine-3′,5′-monophosphate mimics the effect of acetylcholine on slow response action potential and contractile force in mammalian atrial myocardium. J. Mol. Cell. Cardiol. 1978; 10: 573–586
- Wahler G. M., Sperelakis N. Intracellular injection of cyclic GMP depresses cardiac slow action potentials. J. Cyclic Nucl. Prot. Phosph. Res. 1985; 10: 83–95
- Bkaily G, Sperelakis N. Injection of Guanosine-3,5 cyclic monophosphate into heart cells blocks calcium slow channels. Am. J. Physiol. 1985; 248: H745–H749
- Hartzell H. C., Fischmeister R. Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells. Nature 1986; 323: 273–275
- MacLeod K. M., Diamond J. Effects of the cyclic GMP lowering agent LY83583 in the interaction of carbachol with forskolin in rabbit isolated cardiac preparations. J. Pharmacol. Exp. Therap. 1986; 238: 313–318
- Mehegan J. P., Muir W. W., Unverferth D. V., Fertel R. H., McGuick S. M. Electrophysiological effects of cGMP on canine cardiac Purkinje fibers. J. Cardiovasc. Pharmacol. 1985; 7: 30–35
- Wahler G. M., Rusch N. J., Sperelakis N. Inhibition of whole-cell calcium channel current by 8-bromo-cGMP in voltage clamped embryonic chick heart myocytes. Physiologist 1987; 30: 178, (abstract 45.4).
- Sperelakis N, Wahler G. M., Bkaily G. Properties of myocardial calcium slow channels and mechanisms of action of calcium antagonistic drugs. Current Topics in Membranes and Transport, A. Shamoo. Academic, Orlando, FL, 25: 43–76
- Jones L. R., Besch H. R., Jr., Fleming J. W., McConnaughy M. M., Watanabe A. M. Separation of vesicles of cardiac sarcolemma from vesicle of cardiac sarcoplasmic reticulum. J. Biol. Chem. 1979; 254: 530–539
- Lowry O. H., Rosebrough N. J., Fair A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Gill G. N., Holdy K. E., Walton G. M., Kanstein C. B. Purification and characterization of 3′,5′-cGMP dependent protein kinase. Proc. Natl. Acad. Sci. USA 1976; 73: 3918–3922
- Lincoln T. M., Corbin J. D. Characterization and biological role of the cGMP-dependent protein kinase. Advances in Cyclic Nucleotide Research, P. Greengard, G. A. Robinson. Raven Press, New York 1983; 15: 139–192
- Walter U. Cyclic-GMP-regulated enzymes and their possible physiological functions. Advances in Cyclic Nucleotide and Protein Phosphorylation Research, P. Greengard, et al. Raven Press, New York 1984; 249–258
- Wrenn R. W., Kou J. F. cGMP-dependent phosphorylation of an endogenous protein from rat heart. Biochem. Biophys. Res. Commun. 1981; 101: 1274–1280
- Hamet D, Coquil J. F. cGMP binding and cGMP phosphodiesterase in rat platelets. J. Cyclic Nucl. Res. 1978; 4: 281–290
- Geahlen R. L., Krebs E. G. Regulatory subunit of the Type I cAMP-dependent protein kinase as an inhibitor and substrate of the cGMP-dependent protein kinase. J. Biol. Chem. 1980; 255: 1164–1169
- Geahlen R. L., Krebs E. G. Studies of the phosphorylation of the type I cAMP-dependent protein kinase. J. Biol. Chem. 1980; 255: 9375–9379
- Rao M. C., Toskulkao C. Characterization of a 50 kD flounder intestinal phosphoprotein. FASEB J. 1988; 2: A1725, (abstract 8302).